The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
In vivo analysis of Yorkie phosphorylation sites
Open accessAbstract
The co-activator Yorkie (Yki) mediates transcriptional regulation effected by the Drosophila Fat–Warts (Wts)–Hippo (Hpo) pathways. Yki is inhibited by Wts-mediated phosphorylation, and a Wts phosphorylation site at Ser168 has been identified. Here we identify two additional Wts phosphorylation sites on Yki, and examine the respective contribution of all three sites to Yki nuclear localization and activity. Our results show that although Ser168 is the most critical site, all three phosphorylation sites influence Yki localization and activity in vivo, and can be sites of regulation by Wts. Thus, investigations of the role of Yki and its mammalian homolog Yes-associated protein (YAP) in development and oncogenesis should include evaluations of additional sites. The WW domains of Yki are not required for its phosphorylation, but instead are positively required for its activity. We also identify two potential sites of phosphorylation by an unknown kinase, which could influence phosphorylation of Ser168 by Wts, suggesting that there are additional mechanisms for regulating Yki/YAP activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843 · cited 2×
“Phosphorylation of this Ser creates a binding site for 14-3-3 proteins (Basu et al., 2003; Dong et al., 2007; Zhao et al., 2007; Oh and Irvine, 2008), a class of proteins that anchor phosphoproteins in the cytoplasm (Mackintosh, 2004).”
BackgroundWu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640 · cited 2×
“One is the binding to 14-3-3 proteins; the other is the interaction with Sd/TEAD, which promotes nuclear localization (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2008).”
BackgroundThe TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630 · cited 6×
“Investigations of the regulation of Yki and YAP by Wts/Lats identified a critical Ser residue, Ser168 of Yki (Ser127 of YAP) (Dong et al., 2007; Zhao et al., 2007; Hao et al., 2008; Oh and Irvine, 2008; Zhang et al., 2008).”
BackgroundInfluential
Cited by
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Transduction of mechanical and cytoskeletal cues by YAP and TAZ
Halder, G., Dupont, S., & Piccolo, S. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3416 · Cited by 985
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Hong, W., & Guan, K.-L. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.05.004 · Cited by 493
Mechanobiology and Developmental Control
Mammoto, T., Mammoto, A., & Ingber, D. E. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122340 · Cited by 443
Modulating F‐actin organization induces organ growth by affecting the Hippo pathway
Sansores‐Garcia, L., Bossuyt, W., Wada, K., Yonemura, S., Tao, C., Sasaki, H., & Halder, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.157 · Cited by 430
Mechanosensitive mechanisms in transcriptional regulation
Mammoto, A., Mammoto, T., & Ingber, D. E. (2012) · Journal of Cell Science · doi:10.1242/jcs.093005 · Cited by 393
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration
Karpowicz, P., Perez, J., & Perrimon, N. (2010) · Development · doi:10.1242/dev.060483 · Cited by 318
Systemic Organ Wasting Induced by Localized Expression of the Secreted Insulin/IGF Antagonist ImpL2
Kwon, Y., Song, W., Droujinine, I. A., Hu, Y., Asara, J. M., & Perrimon, N. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.02.012 · Cited by 275
Warts and Yorkie Mediate Intestinal Regeneration by Influencing Stem Cell Proliferation
Staley, B. K., & Irvine, K. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.07.041 · Cited by 266
Self-citationSun, G., & Irvine, K. D. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2010.11.036 · Cited by 219
Self-citationZiosi, M., Baena-López, L. A., Grifoni, D., Froldi, F., Pession, A., Garoia, F., Trotta, V., Bellosta, P., Cavicchi, S., & Pession, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001140 · Cited by 184
Modularity in the Hippo signaling pathway
Sudol, M., & Harvey, K. F. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.010 · Cited by 149
Genome-wide Association of Yorkie with Chromatin and Chromatin-Remodeling Complexes
Oh, H., Slattery, M., Ma, L., Crofts, A., White, K. P., Mann, R. S., & Irvine, K. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.008 · Cited by 145
Self-citationThe Angiomotins – From discovery to function
Moleirinho, S., Guerrant, W., & Kissil, J. L. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.006 · Cited by 112
The Hippo Signaling Pathway in Drug Resistance in Cancer
Zeng, R., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13020318 · Cited by 89
JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity
Enomoto, M., Kizawa, D., Ohsawa, S., & Igaki, T. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.05.001 · Cited by 74
Lin, A. Y. T., & Pearson, B. J. (2014) · Development · doi:10.1242/dev.101915 · Cited by 57
Scribble Acts in the Drosophila Fat-Hippo Pathway to Regulate Warts Activity
Verghese, S., Waghmare, I., Kwon, H., Hanes, K., & Kango-Singh, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047173 · Cited by 55
Wittkorn, E., Sarkar, A., Garcia, K., Kango-Singh, M., & Singh, A. (2015) · Development · doi:10.1242/dev.117358 · Cited by 39
Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways
Duhart, J. C., & Raftery, L. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00161 · Cited by 33
Yorkie Growth-Promoting Activity Is Limited by Atg1-Mediated Phosphorylation
Tyra, L. K., Nandi, N., Tracy, C., & Krämer, H. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.011 · Cited by 26
Ji, T., Zhang, L., Deng, M., Huang, S., Wang, Y., Pham, T. T., Smith, A. A., Sridhar, V., Cabernard, C., Wang, J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040147 · Cited by 25
Metadata
- Authors
- Oh, H., & Irvine, K. D.
- Venue
- Oncogene
- Published
- 2009-03-30
- Volume
- 28
- Issue
- 17
- Pages
- 1916-1927
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2003111150
- Cited by
- 195
- References
- 5
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.